Search PubMed⌕ Search

Biomedical subjects

F A Curro

Publications and source records attributed to F A Curro.

25 records · Page 2Linked to original sources

Interaction between alpha adrenergic and serotonergic activation of canine saphenous veins.

Serotonin and norepinephrine produced concentration-dependent contractions of helical strips of canine saphenous veins. The contractile responses to both agonists were inhibited by the alpha adrenergic receptor blocking agent phentolamine. Tolazoline inhibited the contractile responses of canine saphenous veins to norepinephrine but augmented those to serotonin. Blockade of adrenergic neuronal reuptake with cocaine enhanced the sensitivity of the canine saphenous vein to serotonin, but did not suppress the inhibition by phentolamine of the contractile responses to this indolealkylamine. Serotonin-mediated venoconstriction was not secondary to release of norepinephrine since it was not accompanied by an increased release of [7-3H]-norepinephrine. These findings suggest that serotonin does not contract canine saphenous veins by stimulation of typical serotonergic receptors. The binding sites for serotonin and norepinephrine in cutaneous venous smooth muscle may share part of a common receptor complex, which triggers the contractile process. Alternatively, serotonin and norepinephrine may act at two different receptors to elicit contraction of canine saphenous veins.

Animals↗

Effect of vitamin E gel, placebo gel and chlorhexidine on periodontal disease.

The purpose of this study was to compare the effects of a topical 5% vitamin E gel, a placebo gel and chlorhexidine on established and developing plaque and periodontal disease in 48 adult subjects. Baseline data included Plaque Index, Gingival Index and periodontal probing depth. All data were collected by a single calibrated examiner using a double-blind methodology. One group of subjects applied 12 mL of a vitamin E-containing gel delivering 800 mg of alpha-tocopherol, another applied 12 mL of a placebo gel, and the final group rinsed with 0.5 oz of 0.12% chlorhexidine gluconate. After two weeks, the clinical data were again recorded, and two quadrants were randomly selected and treated by root planing and scaling, with data collection repeated after both 4 and 6 weeks. Our results indicated that no significant effects upon plaque or gingivitis were obtainable in either the placebo or the vitamin E groups. However, use of 0.12% chlorhexidine significantly reduced plaque. These results do not support the use of vitamin E as a topical chemotherapeutic agent for the control of gingivitis or periodontal disease.

Adult↗